Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

OBJECTIVES: We previously reported inferior outcomes for locally advanced head and neck cancer treated with cetuximab (C225) versus cisplatin (CDDP). We now examine if this difference persists when accounting for HPV status and update outcomes on the entire cohort. MATERIALS AND METHODS: From 3/106...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Clin Oncol
Main Authors: Riaz, Nadeem, Sherman, Eric, Koutcher, Lawrence, Shapiro, Lauren, Katabi, Nora, Zhang, Zhigang, Shi, Weiji, Fury, Mathew, Wong, Richard, Wolden, Suzanne, Rao, Shyam, Lee, Nancy
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4978947/
https://ncbi.nlm.nih.gov/pubmed/24401670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares